CREATE TRANSFORMATIVE MEDICINES

Translate biology insights into genomic medicines

Latest News

June 13, 2022 — Precision NanoSystems and Aurora Vaccines join forces to accelerate the development of vaccine candidate for Hepatitis C virus Read More

Precision NanoSystems is a global leader in technologies, solutions and services for the development of non-viral delivery of genomic medicines, including mRNA vaccines and therapeutics.

Precision NanoSystems is pleased to join Cytiva and Pall under the Danaher Life Sciences platform. See the press release.
Together with Pall Corporation and Cytiva, Precision NanoSystems further enables development of transformative medicines that improve the lives of patients. PNI, Cytiva, and Pall Corporation offer complementary portfolios from equipment and consumables through to fully flexible manufacturing solutions, designed for the manufacturing of genomic medicine-based therapies from discovery to commercial production.
nxgen

NanoAssemblr®

Platform

The NanoAssemblr instruments feature our proprietary NxGen microfluidic mixer to accelerate genomic medicine development from drug discovery to cGMP manufacturing. 
genovy

GenVoy™ Delivery

Reagents

Off-the-shelf reagent kits and a proprietary clinical lipid nanoparticles (LNP) reagent library designed to deliver nucleic acid medicines.
biopharmaceutical
Biopharmaceutical
Services
Services for proof-of-concept studies in early discovery to advancing lead candidate development for cGMP production.
Woman receiving shot
Prophylactic & therapeutic
Infectious diseases & oncology
Population-based to individualized
Baby sleeping
Silence, express, or edit gene(s)
Focus on rare diseases
Population-based to individualized
Man in hospital bed
Immune cells including T-Cells
Focus on oncology
Autologous & allogeneic
Get Started
Learn how Precision NanoSystems can help accelerate development of genomic medicines.

The proprietary NxGen microfluidic mixer enables the reproducible scale-up of mRNA lipid nanoparticles by preserving the critical conditions at the point of formulation.

scientist
Woman
Precision NanoSystems sets time and place to open a new Genomic Medicine GMP Biomanufacturing Centre in Vancouver, BC.
facility
Partner Team
End-to-end solutions to accelerate the design, development and manufacturing of Genomic Medicines.
kit
Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.